Sign In
Buy ALX
$281.63
-2.52 (-0.89%)
At Close: Jul 17, 2026
Alexander's Announces Fourth Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
10:42am, Wednesday, 21'st Jan 2026
PARAMUS, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it will file its annual report on Form 10-K for the year ended December 31, 2025 with the U.S. Secur
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
11:00am, Thursday, 08'th Jan 2026
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies
- First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician's choice of chemotherapy in HER2-positive metastatic breast cancer; interim a
Best Income Stocks to Buy for December 31st
03:46am, Wednesday, 31'st Dec 2025
ALX, KFRC and BHP made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 31, 2025.
Alexander's Completes Restructuring of Retail Loan at 731 Lexington Avenue
08:44am, Monday, 29'th Dec 2025
PARAMUS, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it has restructured the $300 million mortgage loan on the retail condominium of 731 Lexington Avenue
Alexander’s (NYSE:ALX) Sees Strong Trading Volume – Here’s What Happened
02:55am, Sunday, 28'th Dec 2025
Alexander's, Inc. (NYSE: ALX - Get Free Report) saw unusually-high trading volume on Friday. Approximately 44,573 shares were traded during trading, an increase of 1% from the previous session's volum
Alexander’s (NYSE:ALX) Sees Strong Trading Volume – Here’s What Happened
03:32am, Sunday, 21'st Dec 2025
Alexander's, Inc. (NYSE: ALX - Get Free Report) shares saw an uptick in trading volume on Friday. 54,369 shares traded hands during trading, an increase of 25% from the previous session's volume of 43
Alexander's: Fed Tailwinds Drive FFO Growth
11:37am, Friday, 19'th Dec 2025
Alexander's, Inc. is a commercial REIT managing five properties in New York, with Bloomberg accounting for 60% of revenues. ALX's Q3 2025 results show FFO growth of 2.5%, principally driven by lower f
Alexander’s (NYSE:ALX) Shares Cross Below 200 Day Moving Average – Here’s Why
05:30am, Tuesday, 16'th Dec 2025
Shares of Alexander's, Inc. (NYSE: ALX - Get Free Report) passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $229.44 and traded as low as $214.
Alexander's Completes $175 Million Refinancing of Rego Park II
08:59am, Tuesday, 09'th Dec 2025
PARAMUS, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it has completed a $175 million refinancing of its 615,000 square foot Rego Park II shopping center
- Combination of evorpacept plus rituximab and lenalidomide (R 2 ) generated complete responses (CR) in 92% of patients with untreated indolent non-Hodgkin lymphoma (iNHL) comparing favorably to an ap
Dividends Up To 20% Wall Street Says You Should Sell
09:35am, Saturday, 22'nd Nov 2025
We contrarians follow Wall Street analysts because we like to fade their opinions!
ALX Oncology to Present at Upcoming Investor Conferences
11:00am, Tuesday, 18'th Nov 2025
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline
Best Income Stocks to Buy for Nov. 13
04:56am, Thursday, 13'th Nov 2025
ALX, PFBC and WFRD made it to the Zacks Rank #1 (Strong Buy) income stocks list on Nov. 13, 2025.
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
08:15am, Friday, 07'th Nov 2025
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a
